Abstract: A glass tube for pharmaceutical containers and a manufacturing process for a glass tube are provided. The glass tubes are characterized by a homogenous and low alkali leachability on the inner surface.

Abstract: A glass tube for pharmaceutical containers and a manufacturing process for a glass tube are provided. The glass tubes are characterized by a homogenous and low alkali leachability on the inner surface.

Abstract: A glass tube for pharmaceutical containers and a manufacturing process for a glass tube are provided. The glass tubes are characterized by a homogenous and low alkali leachability on the inner surface.

Abstract: An imaging system, includes: a laser light source having a wavelength from 380 nm to 490 nm; and a beam guidance element, the laser light source configured for generating an average surface power density of more than 10 W/cm2, the beam guidance element including a glass which has a quality factor F(436 nm)=S(436 nm)*(Abs0(436 nm)+Abs1(436 nm))/k, wherein S(436 nm) is a thermality at a wavelength of 436 nm, Abs1(436 nm) is an additional absorbance in comparison to Abs0(436 nm) at a wavelength of 436 nm after an irradiation with a power density of 345 W/cm2 for 72 hours with a laser light having a wavelength of 455 nm, Abs0(436 nm) is an absorbance at a wavelength of 436 nm of a sample having a thickness of 100 mm without the irradiation, k is the thermal conductivity, and the quality factor F(436 nm) is <15 ppm/W.

Abstract: A method for producing a glass article having high hydrolytic resistance is provided. A glass tube consisting of borosilicate glass and having an Al2O3 content of less than 1 weight-%, a ZrO2 content of 2-12 weight-%, and a glass transition temperature Tg is reshaped into a glass article and is subsequently subjected to a thermal post-treatment. To reduce the alkali release of the glass article, the glass article is subjected to a treatment temperature of TB?Tg+5° K over a treatment time of tB?5 min and is subsequently cooled during the thermal post-treatment.

Abstract: A conversion material for a white or colored light source is provided. The material includes a matrix glass that, as bulk material, for a thickness of about 1 mm, has a pure transmission of greater than 80% in the wavelength region from 350 to 800 nm and in the region in which the primary light source emits light, wherein the sum of transmission and reflection of the sintered matrix glass without luminophore is at least greater than 80% in the spectral region from 350 nm to 800 nm and in the spectral region in which the primary light source emits light.

Abstract: Glasses and glass products which combine the chemical temperability with very good alkali and acid resistance, hydrolytic resistance, as well as a desired coefficient of thermal expansion are provided. The glass has a composition characterized by the following constituent phases: a composition characterized by the following constituent phases: 20-60 mol % albite; 0-40 mol % silicon dioxide; 0-20 mol % orthoclase; 0-10 mol % wollastonite; 0-20 mol % enstatite; 0-20 mol % parakeldyshite; 0-20 mol % narsarsukite; 0-40 mol % disodium zinc silicate; 0-20 mol % cordierite; 0-10 mol % strontium silicate; and 0-10 mol % barium silicate.

Abstract: A method for producing a glass article having high hydrolytic resistance is provided. A glass tube consisting of borosilicate glass and having an Al2O3 content of less than 1 weight-%, a ZrO2 content of 2-12 weight-%, and a glass transition temperature Tg is reshaped into a glass article and is subsequently subjected to a thermal post-treatment. To reduce the alkali release of the glass article, the glass article is subjected to a treatment temperature of TB?Tg+5° K over a treatment time of tB?5 min and is subsequently cooled during the thermal post-treatment.

Abstract: A pharmaceutical packaging is provided including a glass, comprising at least the following components (given in mol % on oxide basis): SiO2: 5 9-84, Al2O3: 7-18.5, CaO: 1-25, SrO: 0-6.5, BaO: 0-5, ZrO2: 0-3, TiO2: 0-5, B2O3: 0-1, wherein the ratio (CaO+SrO+BaO)/Al2O3<2.8, wherein the ratio (CaO+SrO+BaO)/SiO2?0.39, wherein the hydrolytic resistance according to DIN ISO 720 is class HGA 1, and wherein the glass, apart from unavoidable contaminations, is free of alkali oxides and magnesium oxides.

Abstract: A conversion material for a white or colored light source is provided. The material includes a matrix glass that, as bulk material, for a thickness of about 1 mm, has a pure transmission of greater than 80% in the wavelength region from 350 to 800 nm and in the region in which the primary light source emits light, wherein the sum of transmission and reflection of the sintered matrix glass without luminophore is at least greater than 80% in the spectral region from 350 nm to 800 nm and in the spectral region in which the primary light source emits light.

Abstract: The invention relates to a conversion material, in particular for a white or colored light source comprising a semiconductor light source as primary light source, comprising a matrix glass that, as bulk material, for a thickness d of about 1 mm, has a pure transmission ?i of greater than 80% in the wavelength region from 350 to 800 nm and in the region in which the primary light source emits light, wherein the sum of transmission and reflection of the sintered matrix glass without luminophore is at least greater than 80% in the spectral region from 350 nm to 800 nm and in the spectral region in which the primary light source emits light.

Abstract: A pharmaceutical packaging is provided including a glass, comprising at least the following components (given in mol % on oxide basis): SiO2:59-84, Al2O3:7-18.5, CaO:1-25, SrO:0-6.5, BaO:0-5, ZrO2:0-3, TiO2:0-5, B2O3:0-1, wherein the ratio (CaO+SrO+BaO)/Al2O3<2.8, wherein the ratio (CaO+SrO+BaO)/SiO2?0.39, wherein the hydrolytic resistance according to DIN ISO 720 is class HGA 1, and wherein the glass, apart from unavoidable contaminations, is free of alkali oxides and magnesium oxides.

Abstract: An optical converter for producing colored or white light from blue excitation light is provided. The converter has good scattering properties to be able to produce nearly white light from the scattered blue light components and the scattered, converted yellow light components. The optical converter includes material including one or more of a YAG ceramic, a LuAG ceramic, and a magnesium-aluminum ceramic exhibiting strong scattering.

Abstract: Borosilicate glasses, preferably for use in the pharmaceutical sector, are provided. The borosilicate glasses are outstandingly suitable for the use as pharmaceutical primary packaging, such as phials or ampoules, since the aqueous or water-containing medicaments kept in the containers do not attack the glass significantly, and so the glass releases no, or only few, ions. The borosilicate glasses have the following composition in % by weight or consist thereof: SiO2 71-77; B2O3 9-12; Al2O3 5.5-8; Na2O 6-8; K2O 0.1-0.9; Li2O 0-0.3; CaO 0-1.5; BaO 0-1; F 0-0.3; Cl- 0-0.3; and MgO + CaO + BaO + SrO 0-2.

Abstract: An optical converter for producing colored or white light from blue excitation light is provided. The converter has good scattering properties to be able to produce nearly white light from the scattered blue light components and the scattered, converted yellow light components. The optical converter includes material including one or more of a YAG ceramic, a LuAG ceramic, and a magnesium-aluminum ceramic exhibiting strong scattering.

Abstract: Borosilicate glasses, preferably for use in the pharmaceutical sector, are provided. The borosilicate glasses are outstandingly suitable for the use as pharmaceutical primary packaging, such as phials or ampoules, since the aqueous or water-containing medicaments kept in the containers do not attack the glass significantly, and so the glass releases no, or only few, ions. The borosilicate glasses have the following composition in % by weight or consist thereof: SiO2 71-77; B2O3 9-12; Al2O3 5.5-8; Na2O 6-8; K2O 0.1-0.9; Li2O 0-0.3; CaO 0-1.5; BaO 0-1; F 0-0.3; Cl- 0-0.3; and MgO + CaO + BaO + SrO 0-2.

Abstract: The invention relates to luminous substances which contain Eu2+ doping and at least one silicate mineral from the garnet group and/or a mono and/or polycrystalline yttrium-aluminum garnet (YAG) and/or a luminous substance derived from Y3Al5O12 by partial or complete substitution, and to the production and use thereof.

Abstract: The invention relates to luminous substances which contain Eu2+ doping and at least one silicate mineral from the garnet group and/or a mono and/or polycrystalline yttrium-aluminum garnet (YAG) and/or a luminous substance derived from Y2Al5O12 by partial or complete substitution, and to the production and use thereof.

Abstract: The invention relates to a conversion material, in particular for a white or colored light source comprising a semiconductor light source as primary light source, comprising a matrix glass that, as bulk material, for a thickness d of about 1 mm, has a pure transmission ?i of greater than 80% in the wavelength region from 350 to 800 nm and in the region in which the primary light source emits light, wherein the sum of transmission and reflection of the sintered matrix glass without luminophore is at least greater than 80% in the spectral region from 350 nm to 800 nm and in the spectral region in which the primary light source emits light.

Abstract: The invention relates to a photovoltaic device having a concentrator optics. The photovoltaic device includes at least one solar cell and a concentrator optics, with the concentrator optics having at least one first, light-input-side, focusing optical element and at least one second optical element downstream of the first, light-input-side optical element and upstream of the solar cell, onto which, in operating position of the photovoltaic device, the bundled solar radiation falls by way of the first optical element, with the second optical element having a solarization-stabilized silicate glass.